Research suggests that CFTR modulators may increase weight in CF patients, the underlying mechanism being multifactorial (improved pancreatic exocrine function, increased calorie intake, and nutrient absorption, decreased energy expenditure due to improved pulmonary function) [34,46,47]. This evidence concerns the gene CFTR and cystic fibrosis.